Willem F. Lems

22.2k citations

406 papers · 15.1k indexed · 2 hit papers · h-index 68

Rheumatology top 0.02%
Orthopedics and Sports Medicine top 0.1%
Molecular Biology top 2%
Surgery top 1%
Oncology top 1%

Co-authors: Ben A. C. Dijkmans Irene E. M. Bultink Michael T. Nurmohamed Alexandre E. Voskuyl Joost Dekker Hennie G. Raterman Maarten Boers Marike van der Leeden
Topics: Rheumatoid Arthritis Research and Therapies (183 papers)Bone health and osteoporosis research (86 papers)Osteoarthritis Treatment and Mechanisms (72 papers)
Cited by: Rheumatology Orthopedics and Sports Medicine Hematology
Journals: New England Journal of MedicineSHILAP Revista de lepidopterologíaAnnals of Internal Medicine
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Willem F. Lems

392 papers receiving 14.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

2005 1.1k citations Cornelia F Allaart, P. J. S. M. Kerstens et al. profile →
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

2007 448 citations Michael T. Nurmohamed, Willem F. Lems et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Willem F. Lems

Since Specialization

Citations

This map shows the geographic impact of Willem F. Lems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem F. Lems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem F. Lems more than expected).

Fields of papers citing papers by Willem F. Lems

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem F. Lems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem F. Lems. The network helps show where Willem F. Lems may publish in the future.

Co-authorship network of co-authors of Willem F. Lems

This figure shows the co-authorship network connecting the top 25 collaborators of Willem F. Lems. A scholar is included among the top collaborators of Willem F. Lems based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem F. Lems. Willem F. Lems is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transition Care for Young Persons with Rare Bone Mineral Conditions: A Consensus Recommendation from the ECTS Rare Bone Disease Action Group 2025 ·Calcified Tissue International ·Corinna Grasemann,(unknown),Natasha M. Appelman‐Dijkstra,(unknown),(unknown),Adalbert Raimann,Heide Siggelkow,Willem F. Lems,Serap Turan,M. Carola Zillikens,Lena Lande Wekre,Inês Alves,(unknown),Maria P. Yavropoulou,Gavin Clunie	0
2	Cartilage tissue turnover increases with high- compared to low-intensity resistance training in patients with knee OA 2023 ·Arthritis Research & Therapy ·Christian S. Thudium,(unknown),Anne‐Christine Bay‐Jensen,Peder Frederiksen,(unknown),(unknown),Marike van der Leeden,Joost Dekker,Willem F. Lems,Leo D. Roorda,W.E. van Spil,M. van der Esch	7
3	Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? 2023 ·Annals of the Rheumatic Diseases ·(unknown),Patrick Verschueren,Maarten Boers,Paul Emery,Pascal H P de Jong,Robert Landewé,Willem F. Lems,Josef S Smolen,T. Huizinga,Cornelia F Allaart,Sytske Anne Bergstra	3
4	Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial 2023 ·Annals of the Rheumatic Diseases ·(unknown),Maarten Boers,Linda Hartman,Daniela Opriș-Belinski,Reinhard Bos,Marc R. Kok,José António Pereira da Silva,E. N. Griep,Ruth Klaasen,Cornelia F Allaart,Paul Baudoin,Hennie G. Raterman,Zoltán Szekanecz,Frank Buttgereit,P. Masaryk,Willem F. Lems,Yvo M. Smulders,Maurizio Cutolo,Marieke M. ter Wee	9
5	Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET 2022 ·RMD Open ·(unknown),Gerben J.C. Zwezerijnen,Marieke M. ter Wee,(unknown),Maqsood Yaqub,Dirkjan van Schaardenburg,Adriaan A. Lammertsma,Alexandre E. Voskuyl,Willem F. Lems,Maarten Boers,(unknown)	7
6	How to implement guidelines and models of care 2022 ·Best Practice & Research Clinical Rheumatology ·Piet Geusens,Natasha M. Appelman‐Dijkstra,M. Carola Zillikens,Hanna C. Willems,Willem F. Lems,Joop P. van den Bergh	2
7	Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial 2022 ·Annals of the Rheumatic Diseases ·Maarten Boers,Linda Hartman,Daniela Opriș-Belinski,Reinhard Bos,Marc R. Kok,José António Pereira da Silva,Eduard N. Griep,Ruth Klaasen,Cornelia F Allaart,Paul Baudoin,Hennie G. Raterman,Zoltán Szekanecz,Frank Buttgereit,P. Masaryk,(unknown),Sabrina Paolino,(unknown),Willem F. Lems,Maurizio Cutolo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	83
8	Whole-Body Macrophage Positron Emission Tomography Imaging for Disease Activity Assessment in Early Rheumatoid Arthritis 2022 ·The Journal of Rheumatology ·(unknown),(unknown),Marieke M. ter Wee,Gerben J.C. Zwezerijnen,Maqsood Yaqub,Alexandre E. Voskuyl,Adriaan A. Lammertsma,Dirkjan van Schaardenburg,Maarten Boers,Willem F. Lems,Conny J. van der Laken	1
9	Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial 2021 ·Osteoporosis International ·(unknown),Marieke M. ter Wee,Debby den Uyl,(unknown),Michael T. Nurmohamed,Alexandre E. Voskuyl,Dirkjan van Schaardenburg,P. J. S. M. Kerstens,Irene E. M. Bultink,Maarten Boers,Willem F. Lems	3
10	Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine 2021 ·RMD Open ·Willem F. Lems,Maarten Boers,Ronald van Vollenhoven,Michael T. Nurmohamed	2
11	Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count 2021 ·Lara D. Veeken ·Linda Hartman,Maurizio Cutolo,Reinhard Bos,Daniela Opriș-Belinski,Marc R. Kok,(unknown),Ruth Klaasen,Cornelia F Allaart,George A. W. Bruyn,Hennie G. Raterman,Marieke Voshaar,Nuno Gomes,Rui M. A. Pinto,(unknown),Willem F. Lems,Maarten Boers	7
12	Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study 2019 ·The Journal of Rheumatology ·Rabia Agca,Luuk H G A Hopman,(unknown),Vokko P. van Halm,Mike J.L. Peters,Yvo M. Smulders,Joost Dekker,Giel Nijpels,Coen D.A. Stehouwer,Alexandre E. Voskuyl,Maarten Boers,Willem F. Lems,Michael T. Nurmohamed	35
13	Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial 2017 ·RMD Open ·Marieke M. ter Wee,Veerle M.H. Coupé,Debby den Uyl,(unknown),(unknown),P. J. S. M. Kerstens,Michael T. Nurmohamed,Dirkjan van Schaardenburg,Alexandre E. Voskuyl,Maarten Boers,Willem F. Lems	5
14	Prevalence and correction of severe hypovitaminosis D in patients over 50 years with a low-energy fracture. 2015 ·PubMed ·E. J. ter Borg,(unknown),Johannes C. Kelder,Willem F. Lems	2
15	Validity of a Calcium Intake List to Estimate Calcium Intake in Patients with Osteoporosis 2014 ·Pure Amsterdam UMC ·Linda A. Rasch,M.A.E. de van der Schueren,(unknown),Irene E. M. Bultink,Willem F. Lems	1
16	Folates and antifolates in rheumatoid arthritis 2013 ·Pteridines ·Gerrit Jansen,Karin Weijers,(unknown),(unknown),Yoony Y. J. Gent,(unknown),(unknown),Carla F.M. Molthoff,Cor L. Verweij,(unknown),Willem F. Lems,Rik J. Scheper,Godefridus J. Peters,Manohar Ratnam,(unknown),Ben A. C. Dijkmans	1
17	Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation 2008 ·Annals of the Rheumatic Diseases ·Vokko P. van Halm,Matthew Peters,Alexandre E. Voskuyl,Maarten Boers,Willem F. Lems,Marjolein Visser,Coen D.A. Stehouwer,Annemieke M. W. Spijkerman,Joost Dekker,Giel Nijpels,R.J. Heine,L.M. Bouter,Yvo M. Smulders,Ben A. C. Dijkmans,Michael T. Nurmohamed	270
18	Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis 2006 ·Obstetrical & Gynecological Survey ·R. N. J. de Nijs,Johannes W. G. Jacobs,Willem F. Lems,Roland Laan,Ale Algra,(unknown),Erik Buskens,Chris De Laet,A. Oostveen,Piet Geusens,George A. W. Bruyn,Ben A. C. Dijkmans,J. W. J. Bijlsma	28
19	Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID- treatment - A randomized, placebo controlled trial. 2004 ·Data Archiving and Networked Services (DANS) ·(unknown),(unknown),Willem F. Lems,(unknown),(unknown),(unknown),(unknown),H. Houben,(unknown),Pieter J. Kostense,Maurits W. van Tulder,Ernst J. Kuipers,(unknown),B.A.C. Dijkmans	1
20	Bone metabolism in rheumatoid arthritis 2000 ·Clinical and Experimental Rheumatology ·Johannes W G Jacobs,R. N. J. de Nijs,Willem F. Lems,J. W. J. Bijlsma	10

About Willem F. Lems

Willem F. Lems is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Medical Terminology, having authored 406 papers that have together received 15.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (183 papers), Bone health and osteoporosis research (86 papers) and Osteoarthritis Treatment and Mechanisms (72 papers). The work is most often cited by research in Rheumatology (8.5k citations), Orthopedics and Sports Medicine (3.6k citations) and Hematology (1.7k citations). Willem F. Lems has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ben A. C. Dijkmans, Irene E. M. Bultink, Michael T. Nurmohamed, Alexandre E. Voskuyl, Joost Dekker, Hennie G. Raterman, Maarten Boers, Marike van der Leeden, Cornelia F Allaart and Gertjan Wolbink. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact